Updates are available Correction dated 2021-09-16
Click to view Correction: https://doi.org/10.1007/s40121-021-00529-0
-
Authors
Aghemo, Alessio
Horsmans, Yves
Bourgeois, Stefan
Bondin, Mark
Gschwantler, Michael
Hofer, Harald
Semmo, Nasser
Negro, Francesco
Zhang, Zhenzhen
Marcinak, John
Veitsman, Ella
Hazzan, Rawi
Mimidis, Konstantinos
Goulis, Ioannis
Marques, Nuno
Flisiak, Robert
Mazur, Wlodzimierz
Roncero, Carlos
Marra, Fiona
Pageaux, Georges Philippe
Asselah, Tarik
Lampertico, Pietro
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03303599 at ClinicalTrials.govDocuments that mention this clinical trial
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
https://doi.org/10.1007/s40121-021-00455-1
-
Funding
Funding for this research was provided by:
AbbVie Inc
- License Information
-
More Information
Article History
Received: 5 March 2021
Accepted: 6 May 2021
First Online: 14 June 2021
Change Date: 16 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-021-00529-0
